The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

Some cancer survivors who have overcome the odds are facing another diagnosis: heart damage, from chemotherapy, radiation or ...

A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...

Heart transplants are complex, costly, and risky—but for patients with heart failure, they are often the only option for ...

Artificial intelligence (AI) can rapidly screen patients for clinical trial enrollment, according to a study published in ...

The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...

A multi-institutional research team led by Osaka University found that tricaprin, a natural supplement, improved long-term ...

A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...

Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for ...